Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection-Regimen for Efficacy And Duration-20 mg/2mL Dose: Tread-20)

NCT00130468 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00130468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00130468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomized Trial of Intra-Articular Injections of 20 mg of Hyalgan® for the Treatment of Knee Pain Due to Osteoarthritis (Three Injection-Regimen for Efficacy And Duration-20 mg/2mL Dose: Tread-20)
Lead sponsor
Sanofi
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2004
Completion date
May 31, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis